Rockwell Medical, Inc., a global healthcare company that develops, manufactures, and distributes hemodialysis products, announced that Rashad Brown has joined as Vice President of Manufacturing and Supply Chain. Mr. Brown brings over twenty years of leadership experience in manufacturing operations, procurement, warehouse management, and supply chain optimization in regulated healthcare environments.
Health Technology Insights: Digital Initiative Strengthens Access to Mental Health Support
“Rashad brings extensive expertise in operational efficiency, lean manufacturing, and strategic supplier management, which aligns with our goal to expand our manufacturing capabilities and maintain high operational standards,” said Mark Strobeck, Ph.D., President and CEO of Rockwell Medical. “His leadership will be key as we enhance our manufacturing processes, ensure reliable product delivery, and support long-term growth. Rashad will help advance our mission to provide dialysis clinics and patients with high-quality products and exceptional service.”
Health Technology Insights: Corvus Launches to Streamline Surgical Referrals and Access to Care
Throughout his career, Mr. Brown has held senior roles at Abbott Laboratories, Fresenius Medical Care, and Hearing Lab Technology. He has managed large teams, overseen multimillion-dollar budgets, and delivered tangible results through lean manufacturing, supply chain optimization, and supplier performance initiatives. His accomplishments include improving gross margins, increasing equipment efficiency through automation, and reducing costs while maintaining compliance in FDA-regulated settings. Mr. Brown is also a U.S. Army veteran, having served in the 7th Special Forces Group.
“I am excited to join Rockwell Medical during this transformative period,” said Mr. Brown. “The Company’s focus on operational excellence and patient care aligns with my values. I look forward to strengthening the manufacturing network, driving innovation, and ensuring reliable, high-quality products for our customers and the patients they serve.”
Health Technology Insights: FDA Approves Interchangeable Status for Fresenius Kabi Biosimilars
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
